BRIEF published on 12/11/2024 at 12:16, 1 year 3 months ago Threshold crossing by the CDC in ABIONYX PHARMA Voting Rights CDC Threshold Crossing ABIONYX Pharma Bpifrance Participations
BRIEF published on 12/11/2024 at 12:13, 1 year 3 months ago Franchissement de seuil par Bpifrance dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions Bpifrance ABIONYX
BRIEF published on 12/11/2024 at 12:13, 1 year 3 months ago Threshold crossing by Bpifrance in ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX
PRESS RELEASE published on 12/11/2024 at 12:11, 1 year 3 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% des droits de vote de ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Franchissement De Seuil Caisse Des Dépôts Et Consignations ABIONYX Pharma Bpifrance Participations 5% Droits De Vote
PRESS RELEASE published on 12/11/2024 at 12:08, 1 year 3 months ago Franchissement de seuil Bpifrance declared indirectly holding 4.67% of Abionyx Pharma's capital and 7.34% of voting rights as of December 5, 2024 Déclaration Franchissement De Seuil AMF Bpifrance ABIONYX Pharma
BRIEF published on 12/10/2024 at 10:51, 1 year 3 months ago Franchissement de seuil par Cyrille Tupin chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions ABIONYX Pharma Cyrille Tupin
BRIEF published on 12/10/2024 at 10:51, 1 year 3 months ago Threshold crossing by Cyrille Tupin at ABIONYX PHARMA Voting Rights Actions Threshold Crossing ABIONYX Pharma Cyrille Tupin
PRESS RELEASE published on 12/10/2024 at 10:46, 1 year 3 months ago Franchissement de seuil Déclaration de franchissement de seuil par M. Cyrille Tupin concernant ABIONYX PHARMA. Détention de 4,56% du capital et 6,06% des droits de vote Déclaration Droits De Vote Franchissement De Seuil ABIONYX Pharma Cyrille Tupin
BRIEF published on 11/14/2024 at 19:05, 1 year 4 months ago ABIONYX Pharma : Bilan financier du troisième trimestre 2024 Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma T3 2024
BRIEF published on 11/14/2024 at 19:05, 1 year 4 months ago ABIONYX Pharma: Third quarter 2024 financial report Biotechnology Treasury Turnover Q3 2024 ABIONYX Pharma
Published on 04/01/2026 at 14:30, 37 minutes ago Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
Published on 04/01/2026 at 14:00, 1 hour 7 minutes ago Dateline Completes A$50M Institutional Placement to Advance Colosseum
Published on 04/01/2026 at 14:00, 1 hour 7 minutes ago Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago
Published on 04/01/2026 at 13:30, 1 hour 37 minutes ago Electric Metals (USA) Limited Announces OTCQB Ticker Symbol Change to EMUS and Grants Deferred Share Units to Directors
Published on 04/01/2026 at 13:30, 1 hour 37 minutes ago First Helium CEO Update Highlights Strategic Positioning of Oil and Helium Assets Amid Global Supply Uncertainty
Published on 04/01/2026 at 14:00, 1 hour 7 minutes ago AlphaPet Ventures acquires Tierliebhaber, the leading brand for pet supplements and functional snacks in Germany
Published on 04/01/2026 at 14:00, 1 hour 7 minutes ago Liechtensteinisches Pfandbriefinstitut successfully issues inaugural bonds
Published on 04/01/2026 at 08:00, 7 hours 7 minutes ago Transfert du contrat de liquidité aupres de Natixis Oddo BHF
Published on 04/01/2026 at 08:00, 7 hours 7 minutes ago Résultats annuels 2025 - ANR par action en hausse de + 8,1 % à 97,10 € - Fonds propres consolidés : 740 M€
Published on 03/31/2026 at 20:08, 18 hours 59 minutes ago SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 20 hours 1 minute ago SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 20 hours 1 minute ago Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
